GL1X · GenesisL1 explorer

Ligand · MRT

MRT · (5R,9S,12S,15S,18S,21S)-21-benzyl-12,18-bis(carboxymethyl)-15-cyclohexyl-1-(9H-fluoren-9-yl)-4-methyl-9-(2-methylpropyl)-3,6,10,13,16,19-hexaoxo-5-phenyl-2-oxa-4,8,11,14,17,20-hexaazadocosan-22-oic acid

MRT, (5R,9S,12S,15S,18S,21S)-21-benzyl-12,18-bis(carboxymethyl)-15-cyclohexyl-1-(9H-fluoren-9-yl)-4-methyl-9-(2-methylpropyl)-3,6,10,13,16,19-hexaoxo-5-phenyl-2-oxa-4,8,11,14,17,20-hexaazadocosan-22-oic acid (C56 H66 N6 O13, 1031.2 g/mol)…

Component
MRT
Formula
C56 H66 N6 O13
Class
ligand
Structures
2
PDB entries
1

Binding sites

MRT in 2 structures; the first of them:

  • 2ZLG · The Structual Basis for Peptidomimetic Inhibition of Eukaryotic Ribonucleotide Reductase · MRT A889 · binds SER691, GLN692, LYS693, ILE696, MET721, GLY722, LYS723, THR725 and 3 more
  • 2ZLG · The structual basis for peptidomimetic inhibition of eukaryotic ribonucleotide reductase · MRT A889 · binds SER691, GLN692, LYS693, ILE696, MET721, GLY722, LYS723, THR725 and 3 more

Residues it binds most

LYS 2, MET 2, SER 2, GLN 2, GLY 2, ILE 2, THR 2, TYR 2 (residue and the binding sites it lines).

Found with

  • GOL · Glycerol

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.